A. Sweet-Cordero
Nature · 2005–2011
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.
Whom A. Sweet-Cordero trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- John D. Storey (in Management Science and Operations Research)
Who trusts A. Sweet-Cordero
- George A. Calin (in Molecular Biology)
- Carlo Maria Croce (in Molecular Biology)
Papers from A. Sweet-Cordero's perspective
Ordered by how strongly the researchers A. Sweet-Cordero trusts endorse each paper. Same corpus, a different order for every researcher.
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repository (Nucleic Acids Res.)
- New uses for old drugs (Nature)
- Human Disease-Drug Network Based on Genomic Expression Profiles (PLoS ONE)
- Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis (PLoS Comput. Biol.)
- An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. (Proceedings of the National Academy of Sciences of the United States of America)
- Global cancer statistics (Ca)
- The price of innovation: new estimates of drug development costs.
- Pvclust: an R package for assessing the uncertainty in hierarchical clustering (Bioinform.)
- Drug repositioning: identifying and developing new uses for existing drugs (Nature reviews. Drug discovery)
- A direct approach to false discovery rates
Their papers
- MicroRNA expression profiles classify human cancers (2005) — 9,882 citations
- Discovery and preclinical validation of drug indications using compendia of public gene expression data (2011) — 746 citations